Hepatitis C Virus Clearance by Direct-Acting Antivirals Agents Improves Endothelial Dysfunction and Subclinical Atherosclerosis: HEPCAR Study

Hepatitis C virus (HCV) infection has been related to increased cardiovascular (CV) risk. The aim of this study was to analyze the impact of sustained virological response (SVR) on endothelial dysfunction and subclinical atherosclerosis in patients with hepatitis C virus treated with direct-acting a...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz-Hernández, Rocío, Ampuero, Javier, Millán, Raquel, Gil-Gómez, Antonio, Rojas, Ángela, Macher, Hada C., Gallego-Durán, Rocío, Gato, Sheila, Montero-Vallejo, Rocío, Rico, María C., Maya-Miles, Douglas, Sánchez-Torrijos, Yolanda, Soria, Isabel Carmona, Stiefel, Pablo, Romero-Gómez, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431267/
https://www.ncbi.nlm.nih.gov/pubmed/32955194
http://dx.doi.org/10.14309/ctg.0000000000000203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431267/
https://www.ncbi.nlm.nih.gov/pubmed/32955194
http://dx.doi.org/10.14309/ctg.0000000000000203

Ejemplares similares